IT·Science
Internet
LG Uplus Teams Up with OptAI to Optimize AI ‘Tokens’
LG Uplus(032640)has partnered with OptAI, a company specializing in AI model optimization, to develop technology that enhances the operational efficiency of AI services.As AI services proliferate, GPU…
Internet
From GPU Center to ‘Smart Factory’… Naver “Accelerates Asia-Pacific AI Factory”
Naver (NAVER(035420)) is accelerating its “Artificial Intelligence (AI) Factory” initiative, which aims to produce large-scale AI. Along with building large-scale AI infrastructure in South Korea, the…
Internet
Melon’s “Forest; Trimming” Feature: Big Bang, Akmu, BLACKPINK, SHINee, and NCT Create Their Own Forests
"Big Bang Forest No. 1" at the Nanjin Hangang Park Lawn. (Photo courtesy of Melon)
#Kakao Entertainment’s music platform Melon announced on the 2nd that it will create five additional forests thro…
Technology
Competitor Drug Faces Challenges in Confirmatory Clinical Trials, HLB INC.’s Ripictu Receives Full Approval… Background on the FDA’s Decision
Few people know the U.S. Food and Drug Administration (FDA) approval process for “Ripicto” (generic name: lirapugratinib) as thoroughly as Jang Seong-hun, former vice president of Eleva Therapeutics. …
Telecommunications & Broadcasting
[Report] “Keeping the Same Number I Used in Korea”… Trying Out SKT’s ‘Family Roaming’ in Okinawa
There’s always a dilemma when planning an overseas trip. You start by comparing prices and data allowances—whether to buy a local SIM card, activate an eSIM, or use your carrier’s roaming service. I t…
Technology
Helixmith and Genome & Company Surge on Royalty News [K-bio pulse]
Korean pharmaceutical, biotech, and healthcare stocks linked to drug commercialization and licensing prospects rallied on September 30.Helixmith rose nearly 20% on expectations of royalties from its C…
Technology
[Bio Spotlight] Gaining Momentum from 'Royalties, Technology Transfers, and Exclusive Rights'… Helixmith Co., Ltd and Genome&Company Soar
On the 30th, Helixmith Co., Ltd(084990)rose nearly 20% on expectations of royalties from the commercialization of a gene therapy by its Chinese partner, while Genome&Company(314130)posted double-digit…
Technology
Peptron, Inc.: Two Years Waiting for Lilly’s Response… Anticipation for Follow-up DDS Contract and Clinical Trial Announcements [Bio Monthly Roundup]
In October, the focus of the domestic pharmaceutical and biotech market is expected to shift to follow-up contracts by drug delivery system (DDS) companies and clinical results to be presented at glob…
Technology
Two Doses of ‘APB-R3’ Provide 12-Week Effect… AprilBio Co.,Ltd. ‘SAFA’ Offers a Glimmer of Hope
AprilBio Co.,Ltd.(397030)The atopic dermatitis treatment “EVO301” (APB-R3), which Safa (SAFA) licensed to U.S.-based Evomune, has reaffirmed its efficacy in a Phase 2a clinical trial and is moving on …
Technology
[Exclusive] A Look Inside the Wallet of KOK’s Chief Finance Officer, Who Is on a ‘Red Notice’… Over 105 Billion Won Cashed Out Through Domestic and International Exchanges
Following the discovery of funds in the wallet of the mastermind behind the KOK Coin (KOK Token) pyramid scheme, evidence has emerged showing that large sums of money also flowed from the virtual asse…